June 14, 2018 / 8:52 AM / in 5 months

Australia's Sirtex Medical accepts $1.4 bln offer from China's CDH Investments

June 14 (Reuters) - Liver cancer treatment firm Sirtex Medical Ltd said on Thursday its board has recommended an offer from China’s CDH Investments to buy the firm for A$1.87 billion ($1.41 billion).

The deal will result in the termination of an agreement to sell itself to Varian Medical Systems Inc, it said in a statement.

CDH and its partner, China Grand Pharmaceutical and Healthcare Holdings Ltd, had offered to pay A$33.60 per share in cash in May. ($1 = 1.3226 Australian dollars) (Reporting by Aaron Saldanha in Bengaluru; Editing by Muralikumar Anantharaman)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below